Economic Benefits of Treating High-Risk Hypertension with Angiotensin II Receptor Antagonists (Blockers)

@article{Coca2008EconomicBO,
  title={Economic Benefits of Treating High-Risk Hypertension with Angiotensin II Receptor Antagonists (Blockers)},
  author={A. Coca},
  journal={Clinical Drug Investigation},
  year={2008},
  volume={28},
  pages={211-220}
}
  • A. Coca
  • Published 2008
  • Medicine
  • Clinical Drug Investigation
Hypertension is one of the leading risk factors for cardiovascular disease and represents a major health and economic burden. Most patients with high-or very high-risk hypertension have multiple cardiovascular risk factors with or without accompanying subclinical organ damage or established cardiovascular or renal disease. Patients with severe hypertension or with moderate hypertension and one to two additional risk factors have absolute 10-year risks of cardiovascular disease of 21–30% and 15… Expand
15 Citations
Patterns and characteristics of hypertension pharmacotherapy in Zimbabwe
  • PDF
...
1
2
...

References

SHOWING 1-10 OF 52 REFERENCES
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.
  • 3,860
  • PDF
...
1
2
3
4
5
...